Vivatides Therapeutics Raises $54M to Expand RNA Therapies
Boston, Massachusetts | April 13, 2026 Vivatides Therapeutics has announced the successful completion of a $54 million oversubscribed Series...
Capital for New Therapy
Kiora Raises $24M to Advance Retinal Therapies
ENCINITAS, California, United States, April 7, 2026 Kiora Pharmaceuticals, Inc. announced the successful completion of a private placement financing...
Ambrosia Biosciences Raises $100M for GLP-1 Pipeline
BOULDER, Colo., USA — March 31, 2026 Ambrosia Biosciences Inc. has announced the successful completion of a $100 million...
Blackstone Raises $6.3B Life Sciences Fund Record
NEW YORK & CAMBRIDGE, Mass., USA, March 30, 2026 Blackstone has announced the final close of Blackstone Life Sciences...
Semarion Secures $3.8M to Advance Drug Discovery Tech
CAMBRIDGE, UK, March 31, 2026 Semarion, a University of Cambridge spin-out company, has announced the successful raise of $3.8...
iDEL Therapeutics Raises €9M to Advance Cancer Pipeline
DORTMUND, Germany, March 17, 2026 iDEL Therapeutics announced the successful close of a €9 million seed financing round led...
Mestag Therapeutics Secures $40M for Clinical Trial
CAMBRIDGE, UK, March 17, 2026 Mestag Therapeutics has announced a $40 million financing round to advance its first-in-class oncology...
Unnatural Products Secures $45M to Advance Peptides
SANTA CRUZ, Calif., March 16, 2026 Unnatural Products has announced the successful closing of a $45 million Series B...
R1 Therapeutics Launches with $77.5M Series A to Advance CKD Treatment
Redwood City, CA – March 17, 2026 – R1 Therapeutics has officially emerged from stealth mode, announcing an oversubscribed...
Equillium Secures $35M Financing to Advance EQ504
LA JOLLA, Calif., March 13, 2026 Equillium Inc., a biotechnology company developing novel therapies for severe autoimmune and inflammatory...